Markers of disease activity in COPD: an 8-year mortality study in the ECLIPSE cohort Source: Eur Respir J, 57 (3) 2001339; 10.1183/13993003.01339-2020 Year: 2021
Characteristics, stability and outcomes of the 2011 GOLD COPD groups in the ECLIPSE cohort Source: Eur Respir J 2013; 42: 636-646 Year: 2013
Clinical examination and all-cause mortality in non-mild COPD population – prospective study Source: International Congress 2019 – Long-term evaluation and control of airway diseases Year: 2019
Predicting 12-month mortality in a Scottish COPD cohort Source: Virtual Congress 2021 – Prediction of exacerbations in patients with COPD Year: 2021
Risk factors for all-cause mortality in patients with COPD: results from the ETHOS trial Source: Virtual Congress 2021 – Inhaled treatments for COPD: clinical trials and real-world studies Year: 2021
The association of comorbidity clusters with long-term survival and incidence of exacerbation in a COPD cohort. The HUNT Study, Norway. Source: Virtual Congress 2021 – COPD burden, epidemiology and management Year: 2021
COPD phenotypes and 5-years mortality risk prediction: PALOMB Cohort Source: Virtual Congress 2020 – Comorbidities/multimorbidites and mortality in patients with chronic lung diseases Year: 2020
All-cause mortality in adults with incident asthma – a 20-year follow-up study of a large population-based cohort of middle-aged Danish adults Source: International Congress 2019 – Long-term lung function: from early birth to adulthood Year: 2019
Cause-specific mortality rates in patients with COPD in primary care: a prospective analysis of the Birmingham COPD Cohort Study Source: Virtual Congress 2020 – Epidemiology and understanding of airways diseases in primary care Year: 2020
Mortality and exacerbation prediction by GOLD groups ABCD 2011 vs. 2017: analysis of the COPDGene cohort Source: International Congress 2017 – COPD management: new findings from large studies Year: 2017
Relationship between supernormal lung function and long-term risk of hospitalisations and mortality: a population-based cohort study Source: Eur Respir J, 57 (4) 2004055; 10.1183/13993003.04055-2020 Year: 2021
Late Breaking Abstract - The association of osteoporosis with mortality and symptom burden in a COPD cohort. The HUNT Study, Norway. Source: International Congress 2018 – COPD exacerbations and bronchiectasis Year: 2018
GOLD classification of COPD and subsequent mortality: findings from a cohort study Source: Annual Congress 2004 - Burden of obstructive lung diseases: costs, mortality and life impairment Year: 2004
Fibrinogen and all-cause mortality in a nationally representative US cohort Source: Annual Congress 2011 - Respiratory epidemiology: comorbidity Year: 2011
10-year cumulative incidence of COPD in a symptomatic cohort using BTS and GOLD spirometric criteria Source: Eur Respir J 2003; 22: Suppl. 45, 214s Year: 2003
GOLD classifications and mortality in COPD: The HUNT study Source: Annual Congress 2013 –Investigating COPD in longitudinal studies Year: 2013
Four-year follow up of a COPD cohort, participation and mortality Source: Annual Congress 2009 - Exacerbations and characteristics of COPD Year: 2009
Comorbidity, hospitalization and mortality in COPD: Results from a longitudinal study Source: Annual Congress 2012 - Distinguishing phenotypes and dealing with comorbidities in primary care Year: 2012
The predictors of COVID-19 mortality in a nationwide cohort of Turkish patients Source: Virtual Congress 2021 – COVID - 19 around the globe Year: 2021
Disease activity in long-term survivors of COPD: 10-years’ follow-up data from the Hokkaido COPD cohort study Source: International Congress 2017 – Current challenges in COPD evaluation Year: 2017